Predictive Factors of Deep Remission Achievement in Patients With Crohn's Disease Treated With Anti-TNF Alfa

被引：0
|
作者：
Sebkova, Ladislava
Rodino, Stefano
D'Amico, Teresa
Sacca, Natale
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [31] EVOLUTION OF ASDAS AND BASDAI IN PATIENTS WITH SPONDYLOARTHRITIS TREATED WITH ANTI-TNF ALFA
    Fonsalia, V.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S114 - S115
  • [32] Proactive TDM for Crohn's Disease Patients in Clinical Remission Under Anti-TNF Treatment: Current State of Evidence
    Torres, Joana
    Bonovas, Stefanos
    Fiorino, Gionata
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (09): : 1338 - 1339
  • [33] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
  • [34] Proteomic markers of response to anti-TNF drugs in patients with Crohn's disease
    Medina-Medina, R.
    Iglesias-Flores, E.
    Benitez, J. M.
    Marin-Pedrosa, S.
    Salgueiro, I.
    Ferrin, G.
    Linares, C. I.
    Gonzalez-Rubio, S.
    Soto, P.
    Gros, B.
    Moral, C.
    Alvarez, F.
    Rodriguez-Peralvarez, M.
    Chicano-Galvez, E.
    Ortea, I.
    Garcia-Sanchez, V.
    Aguilar-Melero, P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S90 - S90
  • [35] Molecular predictors of anti-TNF treatment response in patients with Crohn's disease
    Walczak, M.
    Lykowska-Szuber, L.
    Plucinska, M.
    Michalak, M.
    Krela-Kazmierczak, I.
    Zakerska-Banaszak, O.
    Stawczyk-Eder, K.
    Eder, P.
    Dobrowolska, A.
    Slomski, R.
    Skrzypczak-Zielinska, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S640 - S640
  • [36] The predictive factors of adverse events in psoriatic arthritis patients treated with anti-TNF drugs
    Atzeni, F.
    Ricci, C.
    Ventura, D.
    Caporali, R.
    Cavagna, L.
    Saccardo, F.
    Pellerito, R.
    Gorla, R.
    Marchesoni, A.
    Sarzi-Puttini, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 5 - 5
  • [37] MRI is predictive of, and anti-TNF treatment changes, the clinical course of Crohn's disease strictures
    Schulberg, J. D.
    Wright, E. K.
    Holt, B. A.
    Sutherland, T. R.
    Hume, S. J.
    Ross, A. L.
    Hamilton, A. L.
    Kamm, M. A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S188 - S188
  • [38] Continuation or Switch to Another Anti-TNFα After Intestinal Resection in Crohn's Disease Patients Previously Exposed to Anti-TNFα?
    Collins, Michael
    Sarter, Helene
    Gower-Rousseau, Corinne
    Nachury, Maria
    Libier, Louise
    Cortot, Antoine
    Zerbib, Philippe
    Colombel, Jean-Frederic
    Desreumaux, Pierre
    Blanc, Pierre
    de Chambrun, Guillaume Pineton
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
  • [39] Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease
    Saleem, R.
    Dubois, P.
    Chung-Faye, G.
    Bjarnason, I.
    Hayee, B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S268 - S268
  • [40] Predictive factors of anti-TNF efficacy
    Sarah Onuora
    Nature Reviews Rheumatology, 2017, 13 (11) : 632 - 632
12345